BrainsWay Reports Fourth Quarter and Full-Year 2019 Financial Results and Operational Highlights
Fourth quarter revenues were $6.3 million, up 32% over the same quarter in the prior year. PATTERSON, N.J., March 23, 2020 – BrainsWay...
top of page
News & Events
Mar 15, 2020
BrainsWay Announces Positive Data from Smoking Cessation Multicenter Study Evaluating Use of Deep TM
BrainsWay Announces Positive Data from Smoking Cessation Multicenter Study Evaluating Use of Deep TMS at Society for Research on Nicotine...
Mar 4, 2020
BrainsWay to Participate in Upcoming Investor Conferences
PATTERSON, N.J., March 04, 2020 – BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay”), a global leader in the advanced non-invasive...
Feb 10, 2020
BrainsWay Appoints Avner Lushi to Join Board of Directors
Lushi also to serve on Company’s audit committee PATTERSON, N.J., Feb. 10, 2020 – BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay”), a...
Feb 10, 2020
BrainsWay Reports Results of Interim Analysis of H7 Deep Transcranial Magnetic Stimulation Study in
BrainsWay Reports Results of Interim Analysis of H7 Deep Transcranial Magnetic Stimulation Study in Post-Traumatic Stress Disorder...
Feb 10, 2020
BrainsWay Announces Data from Feasibility Study of Deep Transcranial Magnetic Stimulation System in
BrainsWay Announces Data from Feasibility Study of Deep Transcranial Magnetic Stimulation System in the treatment of Adults with ADHD...
Dec 2, 2019
BrainsWay Announces Successful Results in Pivotal Multicenter Study Evaluating Deep Transcranial Mag
BrainsWay Announces Successful Results in Pivotal Multicenter Study Evaluating Deep Transcranial Magnetic Stimulation System as an Aid in...
Nov 25, 2019
BrainsWay Reports Third Quarter 2019 Financial Results and Operational Highlights
Third quarter revenues were $5.9 million, up 38% over the same quarter in the prior year JERUSALEM, Israel and HACKENSACK, N.J., Nov. 25,...
Nov 25, 2019
BrainsWay Appoints Medical Technology Industry Leader Christopher R. von Jako, Ph.D., as President a
BrainsWay Appoints Medical Technology Industry Leader Christopher R. von Jako, Ph.D., as President and Chief Executive Officer JERUSALEM...
Nov 25, 2019
BrainsWay‘s New Stimulator for Deep Transcranial Magnetic Stimulation Makes German Debut at the 2019
BrainsWay‘s New Stimulator for Deep Transcranial Magnetic Stimulation Makes German Debut at the 2019 German Association for Psychiatry,...
Oct 1, 2019
BrainsWay Announces Innovative Deep Transcranial Magnetic Stimulation System Showcase Presentation a
BrainsWay Announces Innovative Deep Transcranial Magnetic Stimulation System Showcase Presentation at this Year’s Psych Congress Meeting...
Sep 19, 2019
BrainsWay Announces Further Leadership Transition to U.S.
Company Intends to Appoint U.S.-Based CEO JERUSALEM and HACKENSACK, N.J., Sept. 19, 2019 (GLOBE NEWSWIRE) — BrainsWay Ltd. (NASDAQ &...
Aug 26, 2019
BrainsWay Reports Second Quarter 2019 Financial Results and Operational Highlights
Company also announces changes to U.S. Management Team JERUSALEM, Israel and HACKENSACK, N.J., August 26, 2019 – BrainsWay Ltd. (NASDAQ &...
Jul 18, 2019
Groundbreaking Study Demonstrates Advantages of BrainsWay Deep TMS in Treating Major Depressive Diso
Groundbreaking Study Demonstrates Advantages of BrainsWay Deep TMS in Treating Major Depressive Disorder First head-to-head, randomized...
Jun 27, 2019
New Data Published in American Journal of Psychiatry Further Substantiates BrainsWay’s Deep TMS Syst
New Data Published in American Journal of Psychiatry Further Substantiates BrainsWay’s Deep TMS System for the Treatment of Patients with...
Jun 24, 2019
BrainsWay Announces Shipment of 100th Deep Transcranial Magnetic Stimulation Helmet for the Treatmen
BrainsWay Announces Shipment of 100th Deep Transcranial Magnetic Stimulation Helmet for the Treatment of Obsessive-Compulsive Disorder...
Jun 13, 2019
BrainsWay To Present At The 2019 Raymond James Life Sciences And MedTech Conference
JERUSALEM and HACKENSACK, N.J., June 13, 2019 – BrainsWay Ltd. (NASDAQ & TASE:BWAY) (BrainsWay” or the “Company”), a commercial stage...
May 22, 2019
BrainsWay Announces its Multicenter Smoking Cessation Study Has Reached Target Enrollment
More than 260 participants have been enrolled to the study JERUSALEM, Israel and HACKENSACK, N.J., May 22, 2019- BrainsWay Ltd. (NASDAQ &...
Apr 17, 2019
BrainsWay Ltd. Announces Pricing of Initial Public Offering of 2.5 Million American Depositary Share
JERUSALEM, Israel, April 16, 2019 – BrainsWay Ltd. (NASDAQ: BWAY and TASE:BRIN) (“BrainsWay”) today announced that it has priced its...
Mar 26, 2019
BrainsWay Reports Financial Results for Fourth Quarter and Full-Year 2018
Full-Year 2018 revenues of $16.4 million increased 47% over full-year 2017 Fourth quarter revenues of $4.8 million, up 32% over the...
bottom of page